Information News
New assisted suicide guidelines published
26 February 2010
The Director of Public Prosecutions (DPP) has issued new guidelines on whether someone will be prosecuted for helping someone to die.
Teen soap tackles MS
23 February 2010
Teen soap Hollyoaks, which was aired recently on Channel 4 has introduced a storyline depicting one of its characters living with MS.
Fingolimod granted priority review in the States
22 February 2010
Fingolimod (brand name Gilenia) is a new oral treatment for relapsing remitting MS. Applications for licensing were submtted to the regulators in the US and Europe in December 2009. The Food and Drug Administration (FDA) in the US has granted priority review to fingolimod.
MS Trust comments on Radio 5 Risk-sharing Scheme programme
22 February 2010
The Donal MacIntyre show on Radio 5 covered the Department of Health Risk-sharing Scheme last night.
Vitamin D - the latest information
18 February 2010
With much data being published recently about the influence of sunlight and vitamin D on the incidence of MS the MS Trust has produced a new factsheet summarising the latest information.
MS Trust comments on new data on CCSVI
12 February 2010
Preliminary results from a study of CCSVI report an association with people with MS.
Making information about medicines available online
09 February 2010
The MHRA (Medicines and Healthcare products Regulatory Agency), the UK medicines' regulator, is seeking views on making information on medicines available to the public.
MP calls for abolition of the MS drugs risk-sharing scheme
08 February 2010
The Risk-sharing Scheme, the mechanism that makes disease modifying drugs for MS available on the NHS, was debated in Parliament on 2 February.
Oral drugs for MS
02 February 2010
With the new oral drugs continuing to be a focus of interest, the MS Trust has put together information on the research into cladribine and fingolimod.
Exciting new exercise resource launched for people with MS
01 February 2010
Following the success of the book Exercises for people with MS, the MS Trust has launched a new set of web pages full of exercises for people with MS.
More oral MS drug research results published
26 January 2010
Research published in the New England Journal of Medicine (NEJM) suggests that the oral drug cladribine reduces relapse rates and disease progression in people with relapsing remitting MS.
Tysabri labelling changes recommended
22 January 2010
The European Medicines Agency has recommended new measures for dealing with the risks associated with the drug natalizumab (Tysabri).
Oral MS drug research results published
21 January 2010
Research published online today in the New England Journal of Medicine (NEJM) suggests the new oral drug fingolimod may be more effective than current disease modifying drugs for MS.
Has MS affected your work?
20 January 2010
The Multiple Sclerosis International Federation (MSIF) is carrying out a global survey to find out more about how having MS impacts on employment.
MS Trust remains cautious about CCSVI
12 January 2010
With CCSVI again in the news, the MS Trust suggests caution in considering surgery based on what is still a theory being investigated by researchers.
MS more prevalent in people born in spring
04 January 2010
Newly published research from Scotland suggests that babies born in spring face an increased risk of developing multiple sclerosis later in life.
The MS Trust welcomes review of research into cannabis
23 December 2009
A systematic review of randomized controlled trials has reported that cannabis can reduce spasticity in people with multiple sclerosis (MS).
Keep in touch with the MS Trust
22 December 2009
Trying to keep up to date with MS can sometimes seem overwhelming. To help you get straight to the information you want, there are a number of ways you can have news about MS and the work of the MS Trust sent to you directly.
